Help Privacy Policy Disclaimer
  Advanced SearchBrowse




Journal Article

Fine-Tuning Mybl2 is Required for Proper Mesenchymal-to-Epithelial Transition during somatic Reprogramming


Cauchy,  Pierre
Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available

Ward, C., Volpe, G., Cauchy, P., Ptasinska, A., Almaghrabi, R., Blakemore, D., et al. (2018). Fine-Tuning Mybl2 is Required for Proper Mesenchymal-to-Epithelial Transition during somatic Reprogramming. Cell Reports, 24, 1496-1511. doi:10.1016/j.celrep.2018.07.026.

Cite as: https://hdl.handle.net/21.11116/0000-0003-6E7C-8
During somatic reprogramming, Yamanaka's pioneer factors regulate a complex sequence of molecular events leading to the activation of a network of pluripotency factors, ultimately resulting in the acquisition and maintenance of a pluripotent state. Here, we show that, contrary to the pluripotency factors studied so far, overexpression of Mybl2 inhibits somatic reprogramming. Our results demonstrate that Mybl2 levels are crucial to the dynamics of the reprogramming process. Mybl2 overexpression changes chromatin conformation, affecting the accessibility of pioneer factors to the chromatin and promoting accessibility for early immediate response genes known to be reprogramming blockers. These changes in the chromatin landscape ultimately lead to a deregulation of key genes that are important for the mesenchymal-to-epithelial transition. This work defines Mybl2 level as a gatekeeper for the initiation of reprogramming, providing further insights into the tight regulation and required coordination of molecular events that are necessary for changes in cell fate identity during the reprogramming process.